Abstract
Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have